MedPath

Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo

Completed
Conditions
COVID
SARS-CoV 2
Interventions
Diagnostic Test: Serological test
Diagnostic Test: Nasopharyngeal Swab
Diagnostic Test: Oropharyngeal Swab
Registration Number
NCT04408014
Lead Sponsor
Butantan Institute
Brief Summary

Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo

Detailed Description

This is a cross-sectional study to estimate the prevalence of antibodies against SARS-CoV-2 is different population subgroups in the State of São Paulo

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18901
Inclusion Criteria
  • All potential volunteers invited to participate in the study.
Exclusion Criteria
  • All potential eligible participants, but who do not show interest in participating in the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CPP - Butantan Penitentiary Progression CenterOropharyngeal SwabParticipants of the CPP - Butantan Penitentiary Progression Center
CHSP - Penitentiary System Hospital CenterOropharyngeal SwabParticipants of the CHSP - Penitentiary System Hospital Center
SABE (Health, Wellness and Aging)Serological testParticipants of the SABE Project (Health, Wellness and Aging)
ILPI - Long-Term Care Institution for the ElderlyNasopharyngeal SwabResidents of the Long-Term Care Institution for the Elderly of Botucatu
ILPI - Long-Term Care Institution for the ElderlyOropharyngeal SwabResidents of the Long-Term Care Institution for the Elderly of Botucatu
HC-USPNasopharyngeal SwabHome contacts of health professionals diagnosed with COVID-19 at the Hospital of Clínic of Medicine School of the University of São Paulo
CPP - Butantan Penitentiary Progression CenterSerological testParticipants of the CPP - Butantan Penitentiary Progression Center
CORASSerological testRefugees living in the city of São Paulo
CORASOropharyngeal SwabRefugees living in the city of São Paulo
CPP - Butantan Penitentiary Progression CenterNasopharyngeal SwabParticipants of the CPP - Butantan Penitentiary Progression Center
CHSP - Penitentiary System Hospital CenterSerological testParticipants of the CHSP - Penitentiary System Hospital Center
SABE (Health, Wellness and Aging)Nasopharyngeal SwabParticipants of the SABE Project (Health, Wellness and Aging)
ICR-USP - Children's Institute of HCFMUSPNasopharyngeal SwabHome contacts of children and adolescents diagnosed with COVID-19, attended at the Children's Institute of HCFMUSP
HC-USPOropharyngeal SwabHome contacts of health professionals diagnosed with COVID-19 at the Hospital of Clínic of Medicine School of the University of São Paulo
HemocenterSerological testBlood Donors of the Pró-Sangue Hemocenter Foundation of São Paulo
CORASNasopharyngeal SwabRefugees living in the city of São Paulo
CHSP - Penitentiary System Hospital CenterNasopharyngeal SwabParticipants of the CHSP - Penitentiary System Hospital Center
ILPI - Long-Term Care Institution for the ElderlySerological testResidents of the Long-Term Care Institution for the Elderly of Botucatu
ICR-USP - Children's Institute of HCFMUSPSerological testHome contacts of children and adolescents diagnosed with COVID-19, attended at the Children's Institute of HCFMUSP
HC-USPSerological testHome contacts of health professionals diagnosed with COVID-19 at the Hospital of Clínic of Medicine School of the University of São Paulo
SABE (Health, Wellness and Aging)Oropharyngeal SwabParticipants of the SABE Project (Health, Wellness and Aging)
ICR-USP - Children's Institute of HCFMUSPOropharyngeal SwabHome contacts of children and adolescents diagnosed with COVID-19, attended at the Children's Institute of HCFMUSP
Primary Outcome Measures
NameTimeMethod
Prevalence of antibodies against SARS-CoV-2 through serological testing1 month

IgM and IgG antibodies against SARS-CoV-2

Frequency of participants with a positive RT-PCR test result for SARS-CoV-21 month

Positive RT-PCR test result for SARS-CoV-2

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Avenida Vital Brasil 1500

🇧🇷

Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath